43 employees
Foldax is engages in synthetic heart valve development to deliver non-thrombogenic aortic and mitral valves at dramatically lower cost.
2014
$20M
from 4 investors over 4 rounds
Foldax Inc. raised $20M on June 22, 2020
Investors: Angel Physicians Fund, Caltech, BioStar Ventures and Kairos Ventures